Allergy and Infectious Diseases Research in Massachusetts
Allergy and Infectious Diseases Research (93.855) awarded $2.1 billion to recipients in Massachusetts in 1,203 grants from fiscal 2021 to 2025, 9.7% of the program's national total. The General Hospital Corporation received the most, $310 million.
- Awarded in Massachusetts$2.1 billion
- Awards1,203
- Share of the program9.7%
- Rank among states2nd of 52
- National total$22 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 608 | $430 million |
| FY 2022 | 607 | $409 million |
| FY 2023 | 581 | $420 million |
| FY 2024 | 588 | $422 million |
| FY 2025 | 587 | $418 million |
Recipients in Massachusetts
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| The General Hospital Corporation | Nonprofits | 203 | $310 million |
| Brigham & Womens Hospital Inc | Nonprofits | 139 | $266 million |
| The Children's Hospital Corporation | Nonprofits | 120 | $257 million |
| President and Fellows of Harvard College | Colleges and universities | 52 | $217 million |
| University of Massachusetts Medical School | Colleges and universities | 127 | $168 million |
| President and Fellows of Harvard College | Colleges and universities | 99 | $120 million |
| Trustees of Tufts College | Colleges and universities | 96 | $116 million |
| Trustees of Boston University | Colleges and universities | 51 | $105 million |
| Beth Israel Deaconess Medical Center, Inc. | Nonprofits | 33 | $81.6 million |
| The Broad Institute, Inc | Nonprofits | 14 | $58.8 million |
Open opportunities under this program
- Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required)
- Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required)
- Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional)
- Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)
- Immune Tolerance Network (UM1 Clinical Trial Required)
- Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed)
- NLM Institutional Grants for Research Training in Biomedical Informatics, Data Science, and AI (T15 Independent Clinical Trial Not Allowed)
- Accelerating Research and Development of Next Generation Vaccines against Malaria - a Model for Mosquito-Borne Diseases (R61/R33 Clinical Trial Not Allowed)
See all 93 on the program page
Questions people ask
How much Allergy and Infectious Diseases Research money goes to Massachusetts?
$2.1 billion from fiscal 2021 to 2025, across 1,203 awards. Massachusetts ranks 2nd of 52 states and territories for this program.
Who receives Allergy and Infectious Diseases Research money in Massachusetts?
The largest recipient is The General Hospital Corporation, with $310 million in 203 awards. Next are Brigham & Womens Hospital Inc and The Children's Hospital Corporation.
Can organizations in Massachusetts apply now?
Yes, 93 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Allergy and Infectious Diseases Research in other states
Other large programs in Massachusetts
- Grants to States for Medicaid
- Highway Planning and Construction
- Education Stabilization Fund
- Children's Health Insurance Program
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Temporary Assistance for Needy Families
- Federal Transit Formula Grants
- National School Lunch Program
- Aging Research
- Special Education Grants to States